D81.5 Purine nucleoside phosphorylase [PNP] deficiency

Name of the Condition

• Purine nucleoside phosphorylase [PNP] deficiency

Summary

Purine nucleoside phosphorylase (PNP) deficiency is a rare inherited disorder that impairs the immune system, leading to increased susceptibility to infections. This condition results from genetic mutations that disrupt the function of the PNP enzyme, which is critical for purine metabolism and lymphocyte development. The deficiency primarily affects T cells, causing defects in cellular immunity, while B cell function may also be impaired, contributing to combined immunodeficiency.

Causes

PNP deficiency is caused by genetic mutations in the PNP gene, which disrupts the production or function of the purine nucleoside phosphorylase enzyme. These mutations impair the breakdown of purine nucleosides, leading to toxic accumulation and impaired lymphocyte maturation. Inheritance is typically autosomal recessive, meaning both copies of the gene must be mutated for the condition to manifest.

Risk Factors

• Genetic predisposition, often with a family history of immunodeficiency disorders.
• Consanguinity (parents who are closely related) increasing the risk of autosomal recessive forms.
• Certain ethnic backgrounds with higher prevalence of specific genetic mutations.

Symptoms

• Recurrent, severe, or persistent infections (e.g., bacterial, viral, fungal).
• Failure to thrive or delayed growth in infants and children.
• Chronic diarrhea or gastrointestinal issues.
• Neurological symptoms, such as developmental delay or ataxia, in some cases.
• Lymphopenia (low lymphocyte count) on blood tests.

Diagnosis

Diagnosis is based on clinical presentation, laboratory findings, and genetic testing. Blood tests may show lymphopenia, particularly of T cells, and elevated levels of purine metabolites (e.g., deoxyguanosine). Enzyme activity assays can confirm reduced PNP function, and genetic testing identifies mutations in the PNP gene. Additional evaluations, such as immunophenotyping or functional immune tests, may be performed to assess immune system defects.

Treatment Options

Treatment focuses on managing infections and supporting immune function. Options include antimicrobial prophylaxis, immunoglobulin replacement therapy, and hematopoietic stem cell transplantation (HSCT) for severe cases. HSCT is the only curative option, aiming to restore normal immune function by replacing defective immune cells. Supportive care, such as growth monitoring and nutritional support, is also important.

Prognosis and Follow-Up

Prognosis varies depending on the severity of immune defects and timely intervention. Without treatment, the condition can be life-threatening due to recurrent infections. Early diagnosis and HSCT significantly improve outcomes. Long-term follow-up is necessary to monitor immune reconstitution, manage complications, and address developmental or neurological issues. Regular immunological assessments and infection surveillance are standard.

Complications

• Severe, recurrent infections (e.g., pneumonia, sepsis) leading to organ damage.
• Autoimmune disorders or malignancies due to immune dysregulation.
• Neurological complications, including developmental delay or ataxia.
• Failure to thrive or growth retardation in children.

Lifestyle & Prevention

• Avoid exposure to infectious agents (e.g., crowds, sick contacts) to reduce infection risk.
• Practice good hygiene, including handwashing and vaccination (as recommended by a healthcare provider).
• Ensure adequate nutrition and growth monitoring for children.
• Genetic counseling for families to discuss inheritance risks and reproductive options.

When to Seek Professional Help

Seek immediate medical attention for:

• Fever or signs of infection (e.g., cough, diarrhea, rash).
• Unusual or severe symptoms, such as difficulty breathing or neurological changes.
• Recurrent infections that do not respond to standard treatment.
• Concerns about growth or developmental delays in children.

Tips for Medical Coders

When coding for PNP deficiency (ICD10CM code D81.5), ensure documentation supports the diagnosis, including clinical findings (e.g., recurrent infections, lymphopenia) and confirmatory testing (e.g., genetic results or enzyme assays). Note any associated complications or treatments, as these may require additional codes. Verify that the code aligns with the patient's specific clinical presentation and avoid using this code for unrelated immunodeficiencies.